Sartorius/€SRT3
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Sartorius
Sartorius AG, trading under the ticker symbol SRT3, is a global provider of laboratory and bioprocess technologies, offering products and services that cater to the needs of the biopharmaceutical and research industries. Founded in 1870 and headquartered in Göttingen, Germany, the company specializes in filtration, fermentation, fluid management, and laboratory products, supporting clients ranging from research facilities to large-scale biopharmaceutical manufacturers. Operating internationally, Sartorius is crucial in enabling the development and production of biotech medications and vaccines, solidifying its role as a crucial player in the life sciences and biotechnology sectors.
Ticker
€SRT3
Sector
Primary listing
XETRA
Industry
Life Sciences Tools and Services
Headquarters
Employees
13,685
Website
Sartorius Metrics
BasicAdvanced
€12B
-
-
1.24
€0.74
0.38%
Price and volume
Market cap
€12B
Beta
1.24
52-week high
€292.00
52-week low
€166.05
Average daily volume
95K
Dividend rate
€0.74
Financial strength
Current ratio
1.394
Quick ratio
0.77
Long term debt to equity
107.751
Total debt to equity
122.695
Dividend payout ratio (TTM)
48.70%
Interest coverage (TTM)
2.58%
Profitability
EBITDA (TTM)
781
Gross margin (TTM)
45.76%
Net profit margin (TTM)
3.00%
Operating margin (TTM)
13.69%
Effective tax rate (TTM)
26.64%
Revenue per employee (TTM)
€250,000
Management effectiveness
Return on assets (TTM)
2.97%
Return on equity (TTM)
4.46%
Valuation
Dividend yield (TTM)
0.38%
Forward dividend yield
0.38%
Growth
Revenue change (TTM)
3.80%
3-year revenue growth (CAGR)
-3.68%
10-year revenue growth (CAGR)
13.20%
3-year dividend per share growth (CAGR)
-16.26%
10-year dividend per share growth (CAGR)
10.82%
What the Analysts think about Sartorius
Analyst ratings (Buy, Hold, Sell) for Sartorius stock.
Bulls say / Bears say
Sartorius AG achieved a 6.5% increase in Group sales revenue in Q1 2025, with the Bioprocess Solutions division experiencing nearly 10% growth, indicating strong demand for consumables. (webdisclosure.com)
The company's underlying EBITDA rose by 12.2% to €263 million in Q1 2025, with the margin improving to 29.8%, reflecting enhanced operational efficiency. (webdisclosure.com)
Sartorius has set a medium-term target to achieve an underlying EBITDA margin of around 34% by 2028, indicating confidence in sustained profitability growth. (sartorius.com)
In H1 2024, Sartorius reported a 2.2% decrease in sales revenue, with the Lab Products & Services division facing challenges due to the Chinese market, highlighting regional vulnerabilities. (finanzwire.com)
The company adjusted its full-year 2024 guidance to a more cautious stance, citing persistent market volatility and a reluctance from customers to place new orders. (finanzwire.com)
Sartorius's debt-to-equity ratio stands at 117.8%, indicating a high level of leverage that could pose financial risks if not managed effectively. (simplywall.st)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.
Sartorius Financial Performance
Revenues and expenses
Sartorius Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sartorius stock?
Sartorius (SRT3) has a market cap of €12B as of July 26, 2025.
What is the P/E ratio for Sartorius stock?
The price to earnings (P/E) ratio for Sartorius (SRT3) stock is 0 as of July 26, 2025.
Does Sartorius stock pay dividends?
Yes, the Sartorius (SRT3) stock pays dividends to shareholders. As of July 26, 2025, the dividend rate is €0.74 and the yield is 0.38%. Sartorius has a payout ratio of 48.7% on a trailing twelve-month basis.
When is the next Sartorius dividend payment date?
The next Sartorius (SRT3) dividend payment date is unconfirmed.
What is the beta indicator for Sartorius?
Sartorius (SRT3) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.